
|Articles|March 1, 2004
CIBA Vision splits surgical sector
Atlanta-As CIBA Vision Corp. finalizes the sale of its surgical business, a significant portion of the portfolio is being divided. Many of its products are either being sold to a French company, returned to their Israel-based developers, or still in negotiations.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Nanoscope secures new US patent for Multi-Characteristic Opsin (MCO) technology platform
2
Glaucoma innovation: Eight themes to watch in 2026
3
Ollin Biosciences reports positive head-to-head phase 1b data for OLN324 vs faricimab
4
FDA grants Fast Track Designation to Complement Therapeutics’ CTx001 for geographic atrophy
5












































